Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valbenazine Clinical Dependence and Withdrawal Study
NCT03698331Phase 4Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Sep 2018
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of valbenazine in tardive dyskinesia (TD), sponsored by Neurocrine Biosciences. Started Sep 2018; status: completed.
02
Drugs
valbenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT03698331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03698331.